Related references
Note: Only part of the references are listed.Dorsal root ganglia volume is increased in patients with the Fabry-related GLA variant p.D313Y
Tim Godel et al.
JOURNAL OF NEUROLOGY (2019)
Low frequency of Fabry disease in patients with common heart disease
Raphael Schiffmann et al.
GENETICS IN MEDICINE (2018)
Prevalence of Fabry Disease in Young Patients with Stroke in Argentina
Ricardo C. Reisin et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Fabry disease in the Spanish population: observational study with detection of 77 patients
Irene Vieitez et al.
ORPHANET JOURNAL OF RARE DISEASES (2018)
Prevalence of Fabry Disease in Young Patients with Stroke in Argentina
Ricardo C. Reisin et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study
Dominique P. Germain et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2018)
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area
Carmela Zizzo et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2018)
In Silico Analysis of Missense Mutations as a First Step in Functional Studies: Examples from Two Sphingolipidoses
Ana Joana Duarte et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Screening Fabry's disease in chronic kidney disease patients not on dialysis: a multicenter study
Yavuz Yenicerioglu et al.
RENAL FAILURE (2017)
Newborn screening for Fabry disease in the north-west of Spain
Cristobal Colon et al.
EUROPEAN JOURNAL OF PEDIATRICS (2017)
Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria
Keith Nykamp et al.
GENETICS IN MEDICINE (2017)
The D313Y variant in the GLA gene - no evidence of a pathogenic role in Fabry disease
Lis Hasholt et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2017)
Fabry disease due to D313Y and novel GLA mutations
Konstantinos Koulousios et al.
BMJ OPEN (2017)
The mutation p.D313Y is associated with organ manifestation in Fabry disease
M. du Moulin et al.
CLINICAL GENETICS (2017)
Prevalence of Fabry Disease in Familial Mediterranean Fever Patients from Central Anatolia of Turkey
Can Huzmeli et al.
BIOCHEMICAL GENETICS (2016)
Is it Fabry disease?
Raphael Schiffmann et al.
GENETICS IN MEDICINE (2016)
Genetic Screening of Anderson-Fabry Disease in Probands Referred From Multispecialty Clinics
Valentina Favalli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
D313Y mutation in the differential diagnosis of white matter lesions: Experiences from a multiple sclerosis outpatient clinic
Jana Becker et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Epidemiology of Ischemic Stroke
Albert S. Favate et al.
NEUROLOGIC CLINICS (2016)
No Fabry Disease in Patients Presenting with Isolated Small Fiber Neuropathy
Bianca T. A. de Greef et al.
PLOS ONE (2016)
Organ manifestations and long-term outcome of Fabry disease in patients with the GLA haplotype D313Y
Daniel Oder et al.
BMJ OPEN (2016)
D313Y mutation in the differential diagnosis of white matter lesions: Experiences from a multiple sclerosis outpatient clinic
Jana Becker et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease
Bouwien E. Smid et al.
JOURNAL OF MEDICAL GENETICS (2015)
The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: Data from individual patients and family studies
Susana Ferreira et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document
Marieke Biegstraaten et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Nationwide Study on Hypertrophic Cardiomyopathy in Iceland Evidence of a MYBPC3 Founder Mutation
Berglind Adalsteinsdottir et al.
CIRCULATION (2014)
Uncertain diagnosis of Fabry disease: Consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance
B. E. Smid et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Idiopathic Small Fiber Neuropathy: Phenotype, Etiologies, and the Search for Fabry Disease
Kristin Samuelsson et al.
JOURNAL OF CLINICAL NEUROLOGY (2014)
Phenotypical characterization of α-galactosidase A gene mutations identified in a large Fabry disease screening program in stroke in the young
Isabel De Brabander et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2013)
s Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene
Malte Lenders et al.
PLOS ONE (2013)
Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry Disease
Jan Lukas et al.
PLOS GENETICS (2013)
Fabry disease: polymorphic haplotypes and a novel missense mutation in the GLA gene
L. Ferri et al.
CLINICAL GENETICS (2012)
Toward a consensus in the laboratory diagnostics of Fabry disease - recommendations of a European expert group
Andreas Gal et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2011)
Frequency of Fabry disease in male and female haemodialysis patients in Spain
Paulo Gaspar et al.
BMC MEDICAL GENETICS (2010)
Fabry disease in patients with migraine with aura
Beatrice Albano et al.
NEUROLOGICAL SCIENCES (2010)
Belgian Fabry Study Prevalence of Fabry Disease in a Cohort of 1000 Young Patients With Cerebrovascular Disease
Raf Brouns et al.
STROKE (2010)
Frequency of Unrecognized Fabry Disease Among Young European-American and African-American Men With First Ischemic Stroke
Marcella A. Wozniak et al.
STROKE (2010)
Mutations of the GLA Gene in Young Patients With Stroke The PORTYSTROKE Study-Screening Genetic Conditions in PORTuguese Young STROKE Patients
Miguel Viana Baptista et al.
STROKE (2010)
Treat the patient not the lab value
Ramin Tolouian et al.
CLINICAL KIDNEY JOURNAL (2010)
The pulvinar sign: frequency and clinical correlations in Fabry disease
Alessandro P. Burlina et al.
JOURNAL OF NEUROLOGY (2008)
Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy
Lorenzo Monserrat et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Deficient alpha-galactosidase A activity in plasma but no Fabry disease - a pitfall in diagnosis
B Hoffmann et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2005)
Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma
R Froissart et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Fabry disease: Characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele
M Yasuda et al.
HUMAN MUTATION (2003)
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy
B Sachdev et al.
CIRCULATION (2002)
Share Paper
